Does Rallies show KLRS price targets?

Yes. Rallies tracks KLRS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.

Is KLRS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for KLRS. It does not provide personalized investment advice.

KLRS (Kalaris Therapeutics, Inc. Common Stock) Stock Analysis - Analyst Ratings

Kalaris Therapeutics, Inc. Common Stock (KLRS) is a publicly traded Healthcare sector company. As of November 10, 2026, KLRS trades at $2.31 with a market cap of $57.61M and a P/E ratio of 0.00. KLRS moved +0.22% today. Year to date, KLRS is -71.31%; over the trailing twelve months it is -49.87%. Its 52-week range spans $1.78 to $12.90. Analyst consensus is strong buy with an average price target of $15.50. Rallies surfaces KLRS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate KLRS?

3 analysts cover KLRS: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $15.50.

KLRS Key Metrics

Key financial metrics for KLRS
Metric	Value
Price	$2.31
Market Cap	$57.61M
P/E Ratio

EPS	$0.00

Dividend Yield	0.00%

52-Week High	$12.90

52-Week Low	$1.78

Volume	0

Avg Volume	0

Revenue (TTM)	$0

Net Income	$0

Gross Margin	0.00%

Common questions about KLRS

What do analysts rate KLRS?: 3 analysts cover KLRS: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $15.50.
Does Rallies show KLRS price targets?: Yes. Rallies tracks KLRS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is KLRS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for KLRS. It does not provide personalized investment advice.

Kalaris Therapeutics

Analysts

Kalaris Therapeutics

Analysts

KLRS Analyst Consensus

Common questions about KLRS